Artemis Medicare Services Limited Opens Special Window for Transfer and Dematerialisation of Physical Securities
Public notice published in national newspapers on November 17, 2026, inviting shareholders to convert physical shares into demat form
Artemis Medicare Services Limited published a public notice in national newspapers on November 17, 2026, announcing the opening of a Special Window for the transfer and dematerialisation of physical securities. This initiative facilitates shareholders to convert and transfer their physical share certificates into electronic form within a designated period.
Artemis Medicare Services Limited
General / Other
Artemis Medicare Services Limited has announced the opening of a Special Window for the transfer and dematerialisation of physical securities through a public notice published on November 17, 2026. This facility allows shareholders to convert their physical share certificates to electronic format within the specified period.
The company issued the notice in The Financial Express (English) and Jansatta (Hindi) newspapers covering all editions and the Delhi edition respectively on November 17, 2026.
This special window aims to facilitate investors by enabling the transfer and demat of shares that are held in physical form, aligning with regulatory requirements for digitisation.
The initiative follows SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, ensuring transparency and ease of shareholding transfer.
Shareholders holding physical certificates are encouraged to avail of this window to avoid transfer or settlement complications in the future.
Highlights
- Special Window for Transfer and Dematerialisation opened on November 17, 2026.
- Public notice published in The Financial Express and Jansatta newspapers.
- Applicable for shares of Artemis Medicare Services Limited under NSE symbol ARTEMISMED and BSE code 542919.
- Compliant with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
- Facilitates conversion of physical share certificates into dematerialised electronic form.
Key Data Snapshot
What happened
- Artemis Medicare Services Limited published a public notice on November 17, 2026, announcing a Special Window for transfer and dematerialisation of physical securities.
- The announcement is aimed at enabling shareholders to convert physical share certificates into dematerialised form for easier transfer and holding.
Regulatory and governance context
- The public notice complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- This initiative supports regulatory mandates for digitisation and streamlining shareholder securities handling.
Next milestones
- Shareholders need to take action during the Special Window period to complete the transfer and demat process of their physical securities.
- No specific deadline beyond the date of notice was detailed in the filing; shareholders should refer to the notice for timelines.
Highlights
- Special Window for Transfer and Dematerialisation opened on November 17, 2026.
- Public notice published in The Financial Express and Jansatta newspapers.
- Applicable for shares of Artemis Medicare Services Limited under NSE symbol ARTEMISMED and BSE code 542919.
- Compliant with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
- Facilitates conversion of physical share certificates into dematerialised electronic form.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
State Bank of India Engages with Global Institutional Investors in Singapore Hosted by Bank of America
State Bank of India conducted a meeting with major global institutional investors in Singapore on 17th November 2026, hosted by Bank of America, where only publicly available information was discussed.
Read Full StoryIndia Glycols Posts Rs. 358.18 Crore Revenue and Rs. 39.34 Crore EBITDA in Q2 FY27 Post-Demerger
India Glycols Limited announced its standalone unaudited financial results for the quarter ended September 30, 2026, reporting revenue of Rs. 358.18 crore and EBITDA of Rs. 39.34 crore after demerging its Spirits & Biofuel and Biopharma undertakings into separately listed entities.
Read Full StoryIGL Spirits Limited Posts Rs 4,837 Crore Revenue with 14.3% Growth in H1 FY27 Following Demerger
IGL Spirits Limited announced its unaudited financial results for Q2 and H1 FY27, posting a 14.3% year-over-year increase in revenue to Rs 4,837.30 crore and a Profit After Tax of Rs 120.79 crore. These are the company's first comparative results following the April 1, 2026 demerger of its spirits and biofuel business from India Glycols Limited.
Read Full Story